Adding Carboplatin to Neoadjuvant Chemo Improves EFS in Triple-Negative Breast Cancer
There was no significant difference in event-free survival between the carboplatin-containing arms.
Diagnosis & Disease Information
Toripalimab Plus Chemotherapy as First-Line Treatment For Metastatic Esophageal Squamous Cell Carcinoma
Adding toripalimab to standard first-line chemotherapy significantly prolonged survival in patients with advanced esophageal squamous cell carcinoma.
Immunotherapy Significantly Improved Survival in Recurrent/Metastatic Cervical Cancer
The checkpoint inhibitor cemiplimab improved survival in patients with recurrent/metastatic cervical carcinoma compared with single-agent chemotherapy.
dd-MVAC Regimen ‘Should Be Gold Standard’ for Muscle-Invasive Bladder Cancer
Dose-dense methotrexate plus vinblastine, doxorubicin, and cisplatin improved time to progression.
Brigatinib Continues to Best Crizotinib in ALK+ Non-Small Cell Lung Cancer
There was an improvement in progression-free survival despite crossover.
Napabucasin Provides No Added Benefit in Metastatic Pancreatic Cancer
The phase 3 CanStem111P study was terminated early due to futility.
Presence of ctDNA Predicts Worse Outcomes in Early Breast Cancer
The presence of ctDNA, both at baseline and after treatment, was associated with worse survival outcomes.
Real-World Data Suggest Vaccination Reduces Risk of COVID-19 in Patients With Cancer
Most vaccinated patients reported having mild side effects or none at all.
Long-Term COVID-19 Symptoms Linked to Treatment, Survival of Cancer Patients
Long-term symptoms included shortness of breath, chronic fatigue, and neurocognitive dysfunction.
Cancer Cases in Europe Projected to Increase About 20% by 2040
The researchers also projected an increase in cancer deaths.
- Loading...
Loading...
Next post in ESMO 2021
Loading... 
Loading...